key: cord-0810569-hxlotyde
authors: Forsythe, Heather M.; Galvan, Joaquin Rodriguez; Yu, Zhen; Pinckney, Seth; Reardon, Patrick; Cooley, Richard B.; Zhu, Phillip; Rolland, Amber D.; Prell, James S.; Barbar, Elisar
title: Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA
date: 2021-03-29
journal: Biophys J
DOI: 10.1016/j.bpj.2021.03.023
sha: 2be8f6d36571feb289f372f750ffc7d26ebf5da8
doc_id: 810569
cord_uid: hxlotyde

The nucleocapsid phosphoprotein N plays critical roles in multiple processes of the SARS-CoV-2 infection cycle: it protects and packages viral RNA in nucleocapsid assembly, interacts with the inner domain of spike protein in virion assembly, binds to structural membrane protein M during virion packaging and maturation, and binds to proteases causing replication of infective virus particle. Even with its importance, very limited biophysical studies are available on the N protein because of its high level of disorder, high propensity for aggregation and high susceptibility for autoproteolysis. Here we successfully prepare the N protein and a 1000 nucleotide fragment of viral RNA in large quantities and purity suitable for biophysical studies. A combination of biophysical and biochemical techniques demonstrates that the N protein is partially disordered and consists of an independently folded RNA binding domain and a dimerization domain, flanked by disordered linkers. The protein assembles as a tight dimer with a dimerization constant of sub micro molar, but can also form transient interactions with other N proteins facilitating larger oligomers. NMR studies on the ∼100kDa dimeric protein identify a specific domain that binds 1-1000 RNA and show that the N/RNA complex remains highly disordered. Analytical ultracentrifugation, isothermal titration calorimetry, multi-angle light scattering, and cross-linking experiments identify a heterogeneous mixture of complexes with a core corresponding to at least 70 dimers of N bound to 1-1000 RNA. In contrast, very weak binding is detected with a smaller construct corresponding to the RNA binding domain using similar experiments. A model that explains the importance of the bivalent structure of N to its binding on multivalent sites of the viral RNA is presented.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for one of the most significant global public health crises of the past century. The rapid global spread of SARS-CoV-2 has resulted in more than 88,000,000 cases and 1,900,000 deaths worldwide as of January 2021, only one year since it was first identified [1] , with those recovered experiencing serious long-term effects on their physical health [2, 3] . In the wake of such human, social, and economic devastation, there is an urgent need to continue growing and evolving our understanding of structures and functions of SARS-CoV-2 proteins, their role in the viral life cycle, and their potential for vaccine and drug development.

The SARS-CoV-2 virion is composed of 4 structural proteins, spike (S), membrane (M), envelope (E), and nucleocapsid (N). N is the only protein in the nucleocapsid and is the only viral protein that associates with the replicase transcriptase complexes (RTCs) [4] . N proteins bridge a connection between E and M proteins and the ~30kb SARS-CoV-2 genomic RNA (gRNA). Because of these unique interactions, N plays critical roles in multiple processes including, nucleocapsid assembly, virion assembly, mature virion packaging, and replicating and transcribing the single-stranded RNA [5] . Consequently, the N protein is being investigated as a potential drug target [6] [7] [8] , and its low rate of mutation has made it a candidate for vaccine development [9] .

The 422 amino acid N protein is organized into two independently folded domains, the N-terminal domain (NTD) and the C-terminal domain (CTD), flanked by two disordered tails (N IDR and C IDR ), and separated by a 65 amino acid flexible linker ( Figure 1A) . The CTD forms a strong dimer, facilitating dimerization of N ( Figure 1B ) [10] . Experiments performed on SARS-CoV-2 N and the highly conserved SARS-CoV N show that while NTD is the primary RNA-binding domain [11] , both the NTD and CTD are reported to make interactions with genomic RNA (gRNA) [5, 10, [12] [13] [14] [15] . The conserved disordered regions of N contain a SerArg-rich region, the hnRNP1 binding site, the nsp3 binding site, a K-rich region, and the putative TRIM25 E3 Ligase binding site [14, 16, 17] . These disordered regions are also likely to influence gRNA binding, oligomerization, and interactions not yet identified.

Stable dimerization of N and its organization into higher order oligomers in the nucleocapsid are thought to play an essential role in virus particle assembly [18] . SARS-CoV-N forms oligomers in vitro, with a dimer being the dominant species in the absence of gRNA as shown by native gel electrophoresis, size exclusion chromatography and surface plasmon resonance [19] . It is estimated that there are 730-2200 copies of N per SARS-CoV-2 virion [20] , which must coordinate their binding along the 30kb genome, while simultaneously forming stable interactions with other N proteins. The monomeric NTD structure has been solved by both NMR and X-ray crystallography [7, 11, 13, 14] , The crystal structure for the CTD has been solved for a dimer ( Figure 1B) [10, 21] . The CTD is thought to facilitate dimerization of N, but can also pack as an octamer [22] or larger [23] stacking in a helical formation. What is missing is a clear picture of the structure and association state of the full-length SARS-CoV-2 N protein, FL-N, and not just the domains, along with characterization of its binding to gRNA as this information is foundational for any drug development underway to target these essential viral interactions.

Biological condensates are a nearly universal feature of cells to protect RNA during stress. There is increasing evidence for the presence of these condensates in virology such as in measles and HIV, with RNA as a common constituent of these condensates [24] [25] [26] [27] . FL-N phase separates with RNA, and the intrinsically disordered N IDR and linker, as well as the CTD are essential for this process [15, [28] [29] [30] [31] [32] . Different segments of the genome contribute to this phase separation including the 1000nts segment at the 5'-end (1-1000 RNA), which under physiological conditions, condenses with N, and is enhanced at human upper airway temperatures, suggesting an important role during infection [15] . 1-1000 RNA contains several structural elements that are thought to constitute the binding site to N [15] .

Given the importance of N in the virus assembly and replication, this work focuses on the full-length SARS-CoV-2 N (FL-N), and comparison of its structural features to the individual smaller NTD and CTD constructs. We report the first thorough characterization of FL-N and its binding to a 1000 nucleotide segment of the viral RNA (1-1000 RNA) and propose a model that explains the importance of FL-N bivalent structure to its binding affinity on multivalent sites of a long segment of the viral RNA.

Full length SARS-Cov-2-Nucleocapsid phosphoprotein, and CTD corresponding to residues 231-361 were amplified by PCR using plasmid pLVX-EF1alpha-SARS-CoV-2-N-2xStrep-IRES as template (Addgene 141391, a gift from Dr. Krogan) [8] , then cloned into pet24d(+) vector in frame with an Nterminal hexahistidine tag and TEV cleavage site. The plasmid was expressed in E.coli Rosetta cells and cultured in Terrific Broth (TB) media to an OD of 2.0 and induced by 0.5 mM isopropylthio-betagalactoside (IPTG) at 18°C overnight. For NMR, at OD of 0.7, cells were washed twice with MJ9 medium and cultured again at 25% volume of 15 N -NH 4 Cl MJ9 medium for one more hour and induced with 0.5mM IPTG at 30°C for 4 h. The NTD corresponding to residues 47-172 was expressed in frame with an N-terminal His 6-bdSUMO fusion [33] . NTD was grown and expressed in C43 cells in rich autoinducing media or 15 N auto-inducing minimal media for NMR, and grown for 24 h at 37°C.

Plasmids as templates to generate RNA were a generous gift from Dr. Gladfelter [15] . The 5'-end RNA fragment corresponds to the first 1000nts of viral RNA, shown to bind and cause phase separation with N [15] . The IVT and RNA preparation followed protocols established in Iserman et al [15] . Briefly, plasmids were linearized with XbaI restriction enzyme and RNA was synthesized by IVT (NEB E2040S). RNA was further purified by 2.5M LiCl precipitation after DNAse treatment and the size was verified by agarose gel electrophoresis. The same procedure was carried out with Cy3 (Sigma PA53026) labeled RNA.

Protein purification FL-N was purified under denaturing conditions using TALON His-tag purification protocol (Clonetech). Eluted protein fractions in 6M urea buffers were dialyzed in 50mM HEPES pH 7.5, 500mM NaCl, 10% glycerol to refold overnight at 4°C [34] . The refolded protein was further purified by TALON His-tag purification protocol (Clonetech), with all washing steps in 1M NaCl to ensure removal of bound RNA contaminant. FL-N was further purified and separated from soluble aggregate components by gel filtration on a Superdex TM 75 gel filtration column (GE Health). NTD and CTD were purified under native conditions using TALON His-tag purification protocol (Clonetech). Purified NTD was eluted by on-column proteolysis with 30 nM untagged fast acting protease bdSENP1 for 1 hr at 4 o C. Both NTD and CTD were further purified on a Superdex TM 75 gel filtration column (GE Health) in 50mM sodium phosphate 150mM NaCl, pH 6.5. The purity of the recombinant proteins, assessed by SDSpolyacrylamide gels, was >95%. Purified proteins were stored at 4°C with a cocktail of pepstatin and PMSF protease inhibitors and used within 1 week.

Size exclusion chromatography coupled to multi-angle light scattering (SEC-MALS) was carried out using a Superdex TM 200 gel filtration column, on an AKTA-FPLC (GE Healthcare) coupled with a J o u r n a l P r e -p r o o f DAWN multiple-angle light scattering and an Optilab refractive index system (Wyatt Technology). Data for NTD and CTD were collected by injecting 70µM and 100µM protein respectively, in the FL-N NMR buffer (50mM sodium phosphate, 150mM NaCl, pH 6.5) as well as the NTD NMR buffer (20mM sodium phosphate, 20mM NaCl, pH 6.5). FL-N SEC-MALS data were collected with 20µM protein in 50mM sodium phosphate, 150mM NaCl, pH 7.5. Molar mass and error analysis were determined with ASTRA software package v9, employing a Zimm light scattering model (WYATT Technology). RNA binding experiments were carried out with addition 1-1000 RNA to protein to a final ratio of 0.003:1 RNA:protein.

Protein samples were dialyzed overnight, or buffer exchanged into 50mM sodium phosphate, 150mM NaCl, pH 6.5. Concentrations were 22, 38, 59 and 15µM for FL-N, NTD, CTD and FL-N + 1-1000 RNA, respectively. RNA samples were diluted into the same buffer to a final concentration of 90 ng/µL. All analytical ultracentrifugation experiments were performed using a Beckman Coulter Optima XL-A ultracentrifuge, equipped with absorbance optics. Protein partial specific volumes as well as buffer densities and viscosities were estimated using the software sednterp [35] . For sedimentation velocity (SV-AUC) experiments, samples were loaded into epon 2-channel sectored cells with a 12mm optical pathlength. Protein absorbance was monitored at 280 nm and RNA absorbance was monitored at 255 nm. SV-AUC experiments were conducted at 42,000 rpm in a 4 cell Beckman Coulter AN 60-Ti rotor and 20 C. Scans were performed continuously for a total of 300 scans per cell. Data were fit to a continuous c(S) distribution using the software sedfit [36] . Sedimentation coefficients were expressed in Svedbergs (S).

Sedimentation equilibrium experiments were carried out at 5°C to reduce degradation. Three concentrations of each protein were measured, corresponding to 50, 30, and 15µM for CTD and 23, 15, and 8µM for FL-N. Experiments were performed at three speeds, 12,000, 15,000 and 20,000 for CTD and 10,000 for FL-N. Scans were taken every 3 hours to check that equilibrium had been achieved, with final scans taken a minimum of 30 hours after reaching speed. Data were fit to a homodimerization model using the Heteroanalysis software [37] .

Spectra were recorded on a JASCO 720 spectropolarimeter using a 0.1cm cell for NTD and FL-N, and a 0.05cm cell for CTD. Protein samples were dialyzed overnight against 20mM sodium phosphate, 100mM NaF, 1mM sodium azide, pH 7.5 prior to data collection. Spectra were collected at 25°C at a concentration of 14.8, 17 and 30µM for NTD, FL, and CTD respectively. Spectra were acquired from 270nm (not shown) to 200nm to rule out potential RNA signals around 260nm. Buffer spectra were subtracted from sample spectra before the analysis.

Samples were co-dialyzed overnight into 20mM sodium phosphate, 100mM NaF, 1mM sodium azide, pH 7.5, at the same conditions as for CD measurements. 25µL of 40,000U/µL of murine RNase inhibitor (New England Biolab) were added to the RNA dialysis membrane to a total volume of 1mL. For the experiment, 0.3µM of 1-1000 RNA in the syringe was titrated into 15µM FL-N in the cell at 25°C. Binding thermogram was obtained with a VP-ITC microcalorimeter (Microcal, Westborough, MA). Data were fit to a simple single-site binding model.

NMR experiments were collected on a Bruker 800 MHz Avance III HD spectrometer equipped with a triple resonance cryogenic probe. NMR experiments for 15 N FL-N were carried out at 25°C in 50mM J o u r n a l P r e -p r o o f sodium phosphate, 150mM NaCl, pH 6.5 with 10% D 2 O, and a protease inhibitor mixture (Roche Applied Science, Madison, WI). CLEANEX-TROSY experiments for solvent accessibility measurements were collected with a mixing time of 100ms using a recycle delay of 1.5 s. Spectra of 15 N NTD were collected in 20mM sodium phosphate, 20mM NaCl, pH 6.5 in order to transfer assignments from BMRB Entry 34511. Spectra of 15 N CTD were collected at 25°C in 10mM sodium phosphate, 50mM NaCl, 1mM NaN 3 , 1mM EDTA, pH 6.0 in order to accurately compare and transfer assignments from SARS-CoV CTD (BMRB: 17217) All spectra were referenced to DSS. All 2D spectra were processed using Topspin (Bruker Biosciences) and analyzed in CcpNmr. RNA-binding experiments were carried out with the same FL-N or CTD sample as TROSY and CLEANEX. Purified 1-1000 RNA was added to 15 N FL-N or CTD at a molar ratio of 0.008:1 RNA:protein, followed by concentration to the sample's original volume.

Purified protein solutions were dialyzed overnight into 30mM NaCl, 50mM sodium phosphate, pH 6.5 and 7.5 and samples were serially diluted to reach desired concentrations. Turbidity measurements were carried out in two different ways. First, 80µL of samples were transferred into a quartz cuvette and turbidity was measured at 340nm using a Cary 60 UV-Vis ( Fig. 6A ) (Agilent technology). Additional turbidity measurements were carried out in Greiner Bio-one UV-STAR UV-VIS 96-well plates. 20µL of samples were plated in replicates of 3. Plates were then shaken for 30 seconds and turbidity was subsequently measured at 340nm using a BioTek® Synergy HT plate reader. Data points were collected and processed using Gen5 software, version 2.09 ( Fig. 6B and C). Kinetic turbidity measurements were performed by the same plate reader using the kinetic feature on Gen5 with 10 interspaced measurements every 2.5 minutes. RNA was added to a final concentration of 200 and 20ng/µL for 1-1000 RNA and mouse RNA, respectively.

Electrophoretic mobility shift assay (EMSA) RNA was visualized by electrophoretic mobility shift assay in 1% agarose gel. RNA at 0.3µM or 0.5µM was added to increasing concentrations of protein in the range of 0-40µM, and incubated for 20 min at room temperature in a total reaction volume of 10µl. 1µL of 30% glycerol was added to end the reaction before loading on the gel. RNA bands were stained by the Midori Green Nucleic Acid staining solution (Bulldog Bio. Inc. Portsmouth, NH) and visualized by Bio-Rad Gel Doc Image system.

Light microscopy imaging was done using a Zeiss Primo Vert microscope on samples prepared as described for the turbidity measurements. Images were taken using a camera attached to the light microscope. Fluorescence microscopy images were taken on a Keyence BZ-X700/BZ-X710 microscope and a 96-well plate; images were processed using BZ-x viewer and BZ-x analyzer software. For this experiment, cy3-labeled RNA at 90ng/µL was dissolved in 30mM NaCl, 50mM sodium phosphate, pH 6.5 to a final volume of 30µL. After imaging of RNA alone, protein was added to a 15µM final concentration and image capture began immediately thereafter; foci became visible after 5 minutes.

Cross-linking reactions were performed by addition of a 2.3% glutaraldehyde solution in a 1:20 volume ratio. Reactions were conducted in 50mM sodium phosphate pH 7.5 at 37°C for 5 minutes, and stopped by the addition of 1.5M Tris-HCl in a 1:10 volume ratio. Concentrations used for cross-linking assays were 30µM for NTD and dilute FL-N, 60µM for NTD and concentrated FL-N , and 35µM for CTD ( Fig  5C, 5D, 5F ). 1µM or 2µM (2x) 1-1000 RNA was added to NTD or FL-N to a final ratio of 0.03:1 for dilute protein + RNA, or 0.015:1 for concentrated protein plus RNA, and 0.03:1 for concentrated protein + 2x RNA. Urea controls were incubated in either 2M, 4M or 6M urea solutions prior to the crosslinking reaction.

Native mass spectrometry A 50µL aliquot of 20µM FL-N protein was buffer exchanged into 200mM ammonium acetate, pH 7.50, using a Micro Bio-Spin™ column (Bio-Rad Laboratories, Inc.). All ion mobility-mass spectra were collected using a Waters Synapt G2-Si time-of-flight mass spectrometer with a nanoelectrospray ionization (nanoESI) source. A small volume (~3-5 µL) of buffer-swapped sample was loaded into borosilicate capillaries pulled to a ~1µm i.d. tip with a Flaming-Brown P-97 micropipette puller (Sutter Instrument). A platinum wire was placed in electrical contact with the solution, and a voltage of +0.7kV was applied to initiate electrospray. Data were collected with the source at ambient temperature, sampling cone at 25V, trap collision energy at 100V (accurate mass determination) or 25V (ion mobility), transfer collision energy at 5V, and trap gas flow at 5mL/min. A mass calibration profile was generated using cesium iodide cluster ions prior to data acquisition for determination of accurate mass. All ion mobility-mass spectra were acquired with the following conditions: trap wave velocity 300m/s and height 2.0V, IMS wave velocity 500m/s and height 18V, transfer wave velocity 100m/s and height 2.0V. Ion mobility arrival time data were calibrated using β-lactoglobulin, transthyretin, avidin, bovine serum albumin, concanavalin A, and alcohol dehydrogenase as in [38] [39] [40] .

Size exclusion chromatography and multi-angle light scattering (SEC-MALS) of FL-N, NTD, and CTD show that FL-N is predominantly a dimer in solution, with molar mass of 98,250 Da ±3% very close to the calculated molar mass of 97,584 Da for a dimer. The CTD is also a stable dimer in solution with a molar mass of 32,130 Da ±1.6% (35,239 Da, calculated from sequence), while NTD is a monomer with a molar mass of 14,380 Da ±3.5% (14,084Da, calculated from sequence) (Figure 2A ). Secondary structure, assessed by circular dichroism (CD), confirms the model of FL-N ( Figure 1 , Figure  2B ). The NTD CD spectrum shows an unusual positive ellipticity at 228nm, consistent with a structure of an irregular beta-trefoil fold ( Figure 1A ). This maximum is also present in the FL-N spectrum indicating that the structure of the NTD is similar to that in the full length protein. In FL-N, there is also a large negative ellipticity at ~200nm indicative of long segments of disorder, consistent with prediction, and with previously published CD spectra [10] . The CTD spectrum shows a mixture of beta sheets and helices. The sum of the CTD and NTD molar ellipticity spectra is equivalent to the FL-N spectrum without the disordered regions, indicating that the structures of the individual domains are similar to those in the intact protein.

Sedimentation velocity analytical ultracentrifugation (SV-AUC) data show a single sharp peak for each of the NTD and CTD constructs with a sedimentation coefficient consistent with their respective monomer and dimer folded states, while the FL-N shows a peak of considerably larger size, but somewhat broad, indicative of a more disordered structure, sampling multiple conformations ( Figure  2C ).

Native electrospray ionization ion mobility-mass spectrometry (native ESI-IM-MS) clearly indicate the presence of both a monomer and dimer native ion population under these solution conditions ( Figure  2D ). The measured monomer mass of 48699 ± 1 Da compared well with the expected mass based on the sequence of the His-tagged N protein construct (48792 Da). The measured dimer mass of 97465 ± 41 Da J o u r n a l P r e -p r o o f compared well to the expected 97398 Da from the measured monomer mass. Both monomer and dimer populations persisted upon dilution of the sample to approximately 1 µM protein concentration (data not shown). Ion mobility spectrometry measurements, which provide ion size and shape information in the form of ion collision cross-sections (CCS), indicated structures of the monomer and dimer consistent with folded, globular proteins [38, 39, 41] . This conclusion is inferred from the relatively low and narrow charge state distribution observed for both the monomer and dimer ion population [40] . Monomer CCSs ranged from 36.4-44.7 nm 2 over the observed charge states (13-16+), while dimer CCSs ranged from 54.5-59.1 nm 2 for the charge states 18-22+. Both sets of CCS measurements are consistent with the expected two-thirds power law relationship between mass and CCS for folded, globular proteins, indicating that the FL-N monomer retains much of the structure observed in the individual domains.

Sedimentation equilibrium AUC shows that both the CTD construct and FL-N are stable dimers with a dimerization constant of 0.4 µM for FL-N ( Figure S1 ) and 1 µM for the CTD ( Figure S2 ). The dimerization constant of the CTD is based on a global fit of three protein concentrations and four speeds, while the FL-N is based on three concentrations but only one speed, since FL-N partially degraded with time and rendered other speeds not reliable. In general samples for AUC were tested for absence of degradation before and after each run. FL-N degraded within 2-3 days even in the presence of protease inhibitor cocktails, but the CTD remained intact.

Over 250 peaks are visible in the [ 1 H, 15 N]-TROSY spectra of FL-N out of the expected 446 peaks ( Figure 3A ). CLEANEX spectra collected for FL-N revealed that ~150 residues are highly disordered ( Figure 3D ), indicating that in the FL-N, the linkers are disordered as predicted to give rise to CLEANEX peaks. TROSY spectra of NTD and CTD constructs ( Figure 3B , 3C) are similar to those published and assigned earlier [11, 22] . Overlay of NTD TROSY and FL-N CLEANEX shows that nearly all peaks visible in FL-N can be attributed to the NTD domain, and disordered regions ( Figure  3D , 3E, 3F). CTD is not visible in FL-N spectra.

The fact that the NTD peaks and ~150 peaks from the disordered linkers and the IDRs are observed in the spectra, while none of the CTD peaks are observed indicate that in this ~100kDa protein, the linker connecting the NTD with the CTD remains significantly flexible such that the NTD in each subunit behaves independently from the rest of the protein with features similar to those of a monomer. The same is not true for the CTD because it is a folded dimer, and thus its amide peaks are missing in the 100 kDa FL-N. This peak disappearance for the dimerization domain is similar to what we observed for the 66 kDa rabies virus phosphoprotein, which showed peaks for all the residues except for those of the dimerization domain [42] .

Before performing binding studies on FL-N with 1-1000 RNA, we confirmed that the samples in hand can indeed form condensates as previously shown [15] . Using light microscopy, we showed that FL-N forms droplet-like aggregates in the presence of 1-1000 RNA, (Figure 4A ), indicating that further studies with this RNA segment are relevant.

Comparison of FL-N, NTD, and CTD with and without 1-1000 RNA by SEC-MALS reveals that at low molar ratios of RNA:protein (0.003:1), FL-N easily binds to RNA, with the FL-N peak shifting to the left, resulting in a tight N/RNA complex with a corresponding molecular weight of ~70x greater than J o u r n a l P r e -p r o o f FL-N dimer alone ( Figure 4B ). In contrast, the same amount of RNA added to NTD or CTD does not cause detectable peak shift ( Figure 4B) .

Glutaraldehyde cross-linking experiments show that NTD is primarily a monomer in solution (~14kDa), with a small dimer population (~30kDa) only observed at a higher concentration of 60µM. In the presence of RNA (0.03:1 RNA:protein), higher order NTD populations appear (>40kDa) ( Figure 4C ). Cross-linking of CTD without RNA shows a band corresponding to the CTD dimer, consistent with SEC-MALS (~35kDa), and minor populations of larger oligomers (>50kDa) ( Figure 4D) . FL-N crosslinking shows formation of an array of heterogeneous larger oligomers. With the addition of RNA (0.03:1 RNA:protein), FL-N forms a complex too large to migrate through the gel, but with urea, the higher aggregates are not formed for NTD and FL-N ( Figure 4E ). What is clear from this study is that when the individual NTD binds RNA, it forms higher order aggregates suggesting a model in which multiple NTDs, even though they do not dimerize, bind at close enough sites of the RNA to form intermolecular contacts.

From SEC-MALS it is clear that multiple FL-N dimers bind to a single RNA chain, as the FL-N/RNA complex has a molar mass that is about 70x greater than one FL-N dimer bound to 1-1000 RNA (measured molar mass of ~7,000kDa bound to RNA vs ~100kDa free dimer) ( Figure 4B ), suggesting an excess of N dimers bound to this segment of RNA. Furthermore, RNA gels demonstrate significant shifts with FL-N at a ratio of 0.015-0.02:1 RNA:Protein, resulting in a smear of larger complexes ( Figure 5A ). Comparison of gel shifts of FL-N, NTD, and CTD, show that for FL-N and NTD, there is a shift with 10µM or more protein (a ratio of 0.05-0.01:1), but for CTD, a significant shift is not apparent until at 20µM protein (0.025:1) estimating a Kd of RNA binding of about 20µM ( Figure 5B ). With LC8, a non-RNA binding protein and shown here as a control, there is no gel shift with increasing protein concentration ( Figure 5B ). Fluorescence imaging of 1-1000 RNA with a Cy3 fluorescent tag demonstrates that RNA-Cy3 alone is uniformly dispersed throughout the solution, but with the addition of FL-N, becomes organized and condensed ( Figure 5C ), similar to previous reports [15] . FL-N binding to 1-1000 RNA measured by isothermal titration calorimetry gives a binding isotherm with an estimated Kd value of 0.1µM (∆G = -9.5 kcal/mol), and a stoichiometry of 0.0027:1 RNA:protein. This large ratio is consistent with the ratio observed with SEC-MALS, indicating that for every 1-1000 RNA strand, 70-187 N-protein dimers are bound, depending on sample conditions and the method used ( Figure 5D ). Binding is accompanied by very large entropic and enthalpic contributions (T∆S =-408 kcal/mol), ∆H = -417 kcal/mol) which is not surprising for this large number of multivalent interactions. Analytical ultracentrifugation measurements recorded at 255nm to bias signal towards RNA present a clear difference between free RNA and RNA bound to FL-N, with free RNA sedimenting as a single broad peak with a sedimentation coefficient of 4 S, ( Figure 5E ). In contrast, FL-N/1-1000 RNA produced a heterogeneous sedimentation profile with s values on a scale 10x greater than free RNA, suggesting formation of multiple large complexes of variable stoichiometry ( Figure 5F ).

The turbidity of FL-N increases in the 5-20µM protein concentration with RNA purified from mouse skin fibroblast, and reaches a plateau or slightly decreases with increasing concentrations ( Figure 6A ). After 2 hours of incubation, turbidity is significantly decreased (FLN+RNA 2h). When FL-N is incubated with 1.1µM 1-1000 viral RNA at multiple protein concentrations in pH 6.5 and 7.5, higher turbidity is observed overall at pH 6.5, with a significant difference arising only between free and RNA-J o u r n a l P r e -p r o o f bound at a concentration of 50µM FL-N ( Figure 6B ). Higher turbidity is observed for binding the nonspecific mouse RNA relative to 1-1000 RNA, and similar to an earlier report, higher turbidity is observed with lower pH [28] . NTD alone does not show turbidity with the addition of 1-1000 RNA, regardless of protein concentration ( Figure 6C ), although there was some turbidity with the nonspecific RNA ( Figure 6A) . Therefore, what these experiments show is that turbidity is highest with FL-N and when RNA is bound at lower pH.

Upon addition of a small molar ratio of 1-1000 RNA to 15 N labeled FL-N (0.008:1), NMR spectra show that peaks corresponding to the NTD decrease in intensity or disappear completely ( Figure 7A) . A majority of peaks corresponding to the most disordered residues remain mostly unchanged, with only a few CLEANEX peaks decreasing in intensity ( Figure 7B ). Resonance assignments of NTD were obtained by comparing our spectra to published assignments at similar conditions (BMRB Entry 34511). Mapping the change in intensity in FL-N upon binding to RNA on the NTD structure shows that the majority of the peaks have decreased in intensity (orange), and only few unchanged (white) ( Figure 7C ). Residues that increase in peak intensity (dark purple) are largely due to peak overlap ( Figure 7C ). Since the majority of the peaks within the NTD disappear, we conclude that the full NTD domain is locked in a bound conformation and that the IDRs of FL-N do not significantly contribute to binding as they do not change in peak intensity nor chemical shifts.

Within the SARS-CoV-2 nucleocapsid, hundreds to thousands [20] of N proteins package the gRNA, while maintaining their ability to make other protein interactions, such as with the membrane (M) protein within a fully formed virion [30] , and with papain-like protease non-structural protein 3 (Nsp3), enabling transfer of gRNA to a replicase [14] . In this space, the N protein must also make organized, favorable interactions with other N proteins. While there have been a large number of reports on atomic level characterization of the N protein, the majority are focused on structural characterization of the smaller NTD and CTD domains [7, 11, 14, 29, 43] . Characterization of FL-N is scarce and limited to conflicting reports of the association state [10, 44, 45] . Furthermore, the few biophysical studies that incorporate RNA binding, either on individual domains or FL-N, have been limited to short segments of RNA, or to synthesized polynucleotide RNA models, rather than the viral RNA [11, 14, 43, 46] . These limited and conflicting reports are not surprising considering that the FL-N is a large multidomain protein with three long disordered segments, is prone to autoproteolysis [47] , and aggregation as well as nonspecific binding of bacterial proteins and RNA during recombinant expression and purification, as we find in our studies. Our work here offers the first thorough characterization of FL-N and its binding to a 1000 nucleotide segment of the viral RNA, and presents a model that explains the importance of FL-N bivalent structure to enhancing its binding affinity on multivalent sites of a long segment of the viral RNA. Figure 2 ) with a dimerization constant that is lower than 0.5µM estimated from the loading protein concentration by SEC, and of 0.4µM measured from AUC at a single speed ( Figure S1 ), while CD and NMR reveal a structure composed of folded NTD and CTD domains that retain the structures of the individual constructs. These domains are linked and flanked by disordered linkers that provide significant flexibility to the NTD within the 100kDa dimer sufficient to show sharp peaks in the TROSY HSQC spectra (Figure 3 ). Native mass spectrometry identifies a monomeric species in addition to the dimer that has folded domains and is populated at low protein concentrations (Figure 2) , while cross-linking and turbidity measurements J o u r n a l P r e -p r o o f suggest the formation of larger N oligomers at high protein concentration and lower pH. These results show that a stable dimer is the primary species but also explains the conflicting reports of different association states in the literature.

The FL-N protein binds to the 1-1000 RNA to form a tight heterogeneous complex, while under similar conditions, no binding is observed to the individual NTD and CTD domains by SEC-MALS ( Figure  4B ). We attribute the tighter binding to the bivalent nature of FL-N which uses the two flexible NTD domains that are anchored by the CTD dimerization domain to latch on the RNA. With cross-linking experiments, the NTD forms larger oligomeric states in the presence of higher RNA to protein ratios than what is used in SEC-MALS or NMR (0.03:1 instead of 0.003:1) suggesting that the NTD on its own can weakly bind RNA. As NTD binds to RNA, localized NTD concentrations increase to favor some NTD intermolecular association, resulting in >40kDa protein complexes ( Figure 4C) . FL-N crosslinking with the same amount of RNA results in a complex too large to enter the well of the gel ( Figure  4E ). Therefore, FL-N most readily oligomerizes, without RNA, and most readily binds to RNA. CTD on its own also readily oligomerizes, but oligomerization of the NTD can occur at a higher concentration and in the presence of RNA, underscoring the importance of bivalent N for efficient interactions with RNA. FL-N binding to RNA creates heterogeneous complexes observed by RNA gel shift assays, fluorescence microscopy, and AUC ( Figure 5 ). Therefore, taken together these results show that FL-N binds to 1-1000 RNA in multiple locations simultaneously forming complexes with diverse sizes, rather than creating a few distinct oligomeric species.

FL-N's multivalent binding to RNA assessed by NMR reveals that in the context of FL-N and with a 1000nt region of SARS-CoV-2 RNA, all of the NTD is impacted by binding, supporting a model that multivalent binding along RNA brings together many copies of NTD, changing the tumbling rate and chemical environment of NTD as a whole, rather than only impacting key RNA-binding residues as observed previously with small segments of RNA [11, 14] . Disorder remains largely unaffected by RNA binding (Figure 7B ), as disordered regions do not appear to gain structure, or make significant interactions with other regions of FL-N. Since within the disordered linker resides the SR-rich region, the hnRNP1 binding site, and the nsp3 binding site, and within the C-terminal IDR is a K-rich region and the putative TRIM25 E3 Ligase binding site, it seems essential for proper function of the N protein that these disordered regions remain disordered and available for binding or for phosphorylation. Characterization of FL-N association and multivalent RNA binding is critical for understanding the viral life cycle, and could inform potential drug therapy, as both the NTD [6, 7, 48, 49] and CTD [50] are potential drug targets. Therefore, developing compounds that either disrupt the RNA-binding or dimerization, requires understanding of not only how these compounds interfere with the individual domains, but with the larger protein:RNA complexes involving many FL-N copies, and longer RNA [6] [7] [8] . Since we see different RNA-binding behavior with FL-N compared to individual domains, we expect that compounds developed to disrupt dimerization would also disrupt RNA binding and larger nucleocapsid assembly. Furthermore, since RNA binding affinity is different in the FL-N and individual domains, investigations into drug compound interactions with the N-protein must be done on FL-N protein along with individual domains.

Our work presented here illustrates a model of how the SARS-CoV-2 nucleocapsid phosphoprotein assembles multivalently along its ~30kb genome (Figure 8 ). Flexible and dimeric in solution, the bivalent N can maintain a propensity to form large, heterogeneous oligomers, originating in the CTD. While both the NTD and CTD domains of FL-N bind to the 1-1000 RNA, the NTD is the primary RNAbinding domain and can only bind efficiently when part of the FL-N and not as an individual domain. As NTD binds to many sites on 1-1000 RNA, the increase in effective protein concentration facilitates increased oligomerization, and organization of RNA. Organization of the ~30kb genome by N proteins results in a ribonucleoprotein (RNP) that is dynamic, with the disordered regions of N remaining disordered and primed for further interactions.

In summary, the N protein is a partially disordered duplex that binds significantly tighter to RNA than its individual domains, demonstrating that it is necessary for the NTD to be part of a bivalent duplex for efficient binding. Another major novel finding is binding to the 1000 nt RNA, the largest viral RNA studied to date by biophysical methods, results in a heterogeneous N/RNA complex with an N to RNA ratio in the range of 70-187 dimers per RNA with 70 dimers making the most stable core, and with the NTD being the primary binding domain while the disordered linkers are not affected in the N/RNA complex. The remaining disorder in the N/RNA complex is essential for the multi-faceted roles of N in viral replication. . Residues corresponding to peaks that decrease in intensity upon binding are colored orange. Residues corresponding to peaks that increase in intensity upon binding, colored in purple, are attributed to peak overlap. Residues not present in our construct or that do not have peaks visible in TROSY spectra are colored black. In solution, N proteins exist as dimers with disordered linkers but could make larger oligomers through CTD interactions at high protein concentration. B. In the presence of RNA, the NTD binds multivalently along the RNA, bringing N proteins into closer contact with each other, making contacts with other N proteins primarily through the CTD. Localized higher concentrations enable NTD to make intermolecular interactions with other NTDs. C. FL-N binds to RNA at multiple sites along the strand, resulting in the formation of heterogeneous complexes. D. As more N proteins become available, stabilizing interactions between RNA and proteins result in an organized nucleocapsid. 

WHO Coronavirus Disease (COVID-19) Dashboard. Geneva: World Health Organization

Persistent symptoms in patients after acute COVID-19

Management of post-acute covid-19 in primary care

Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle

The coronavirus nucleocapsid is a multifunctional protein

Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In silico analysis

Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochemical and biophysical research communications

Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein

Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA

Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein

Structural Insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein. Computational and structural biotechnology journal

Genomic RNA elements drive phase separation of the SARS-CoV-2 nucleocapsid

Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses

Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication

Coronavirus nucleocapsid proteins assemble constitutively in high molecular oligomers. Scientific reports

In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS

Science Forum: SARS-CoV-2 (COVID-19) by the numbers. Elife, 2020

Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein. Molecular Biomedicine

Solution structure of the c-terminal dimerization domain of SARS coronavirus nucleocapsid protein solved by the SAIL-NMR method

The SARS coronavirus nucleocapsid protein--forms and functions

Structure, dynamics and phase separation of measles virus RNA replication machinery. Current opinion in virology

A lipid-based partitioning mechanism for selective incorporation of proteins into membranes of HIV particles

Measles virus nucleo-and phosphoproteins form liquid-like phase-separated compartments that promote nucleocapsid assembly. Science advances

Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking

SARS-CoV-2 nucleocapsid protein phase-separates with RNA and with human hnRNPs

Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates

The SARS-CoV-2 Nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. bioRxiv

The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA

Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA

Purification of protein complexes of defined subunit stoichiometry using a set of orthogonal, tag-cleaving proteases

Phosphorylation modulates liquid-liquid phase separation of the SARS-CoV-2 N protein

Computer-aided interpretation of analytical sedimentation data for proteins. Analytical ultracentrifugation in biochemistry and polymer science

Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling

Analytical ultracentrifugation: sedimentation velocity and sedimentation equilibrium

Collision cross sections of proteins and their complexes: a calibration framework and database for gas-phase structural biology

Traveling-wave ion mobility mass spectrometry of protein complexes: accurate calibrated collision cross-sections of human insulin oligomers. Rapid Communications in Mass Spectrometry

Native ion mobility-mass spectrometry and related methods in structural biology

Extended protein ions are formed by the chain ejection model in chemical supercharging electrospray ionization. Analytical chemistry

The LC8-RavP ensemble Structure Evinces A Role for LC8 in Regulating Lyssavirus Polymerase Functionality

Structure of the N-Terminal RNA-Binding Domain of the SARS CoV Nucleocapsid Protein

Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein. bioRxiv

High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2. Biochemical and biophysical research communications

Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerization domain suggests a mechanism for helical packaging of viral RNA

Autoproteolytic Products of the SARS-CoV-2 Nucleocapsid Protein are Primed for Antibody Evasion and Virus Proliferation. bioRxiv

The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery

Computational guided identification of novel potent inhibitors of N-terminal domain of nucleocapsid protein of severe acute respiratory syndrome coronavirus 2

Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations

This work is funded by an NSF EAGER MCB 2034446 to EB. The authors wish to acknowledge the COVID team at Oregon State University in particular Dr. David Hendrix and Brittany Lasher for many helpful discussions, and Dr. Michael Hare of e-MSion for mass spectrometry sample analysis. We also acknowledge the support of the Oregon State University NMR Facility funded in part by the National Institutes of Health, HEI Grant 1S10OD018518, and by the M. J. Murdock Charitable Trust grant #2014162. Native mass spectrometry data acquisition was supported by an NIH T32 GM007759 (to A.D.R.). A.D.R. is an ARCS Scholar supported by the ARCS Oregon Chapter.